Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Post by inviolablspiriton Oct 23, 2024 2:36pm
108 Views
Post# 36278975

MDMA

MDMAI know there is a lot of excitement around this stock as there should be, the future looks very bright.  However, I'm still on the side that it would be nice to see a healthy pullback due to the techncials still signaling overbought. That seems to be where we currently are with this stock, as selling pressure continues.   In a previous post last week I did mention that remaining in the overbought technically when great news is dropped can be wasted and we saw that to a degree with the Mount Sinai news release.  The Mount Sinai was incredible news, but the stock could not hold the gains due to the stock price being well into the overbought side of the technicals.  The stock ran up while already in the overbought and the day traders hammered it down due to sell signals.  So I'm good to hold around here as the technicals work their way down for the next run.  The buying and selling of the stock is definitely retail.  Institutional buys and sells would crank the volume into the 10's of millions of shares. 

I know I'll get some word salad response from Mr. Chef-boy-r-dee for this post about being part of these day traders, but I'm not.  I just want to see the stock get into a healthy position technically so news releases don't get wasted and the stock can hold the higher gains.  And if I have a few extras dollars to throw onto the stock in a pullback, I will.  

<< Previous
Bullboard Posts
Next >>